Gene Query: OSGEP

Dataset Description Geneva Score
Cleavage Factor Im as a key regulator of 3’ UTR length 26.67
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 24.71
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 14.78
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 14.48
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 11.18
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 11.02
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 10.43
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 9.85
Novel Targeting of Transcription and Metabolism in Glioblastoma 9.51
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 9.19
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 8.37
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 8.37
HEK293 TFAM Knockout Expression Study 8.36
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 8.27
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 8.16
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 7.73
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 7.73
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 7.71
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 7.7
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 7.7
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 7.59
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 7.53
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 7.38
A role for ZNF598 in post-transcriptional gene regulation 7.31
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 7.25
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 6.92
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 6.76
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 6.7
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 6.56
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 6.52
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 6.48
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 6.34
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 6.25
Next Generation RNA Sequencing Analysis of AMPK Wild Type, AMPKα-KO and AMPKα1-2A U2OS cell Transcriptomes 6.24
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 6.16
Biological effect of chronic mistranslation in mammalian cells 6.05
Dysregulated immune system networks in war veterans with PTSD 5.96
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 5.89
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 5.86
CROP-Seq in Primary Human T Cells 5.77
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 5.75
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 5.71
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 5.7
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 5.7
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 5.51
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 5.46
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 5.44
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 5.43
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 5.41
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 5.22
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 5.21
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.19
Transcriptional profiles of normal human mature B cells 5.13
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.09
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 4.98
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 4.98
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 4.94
Pharmacologic inhibition of STAT5 in AML 4.88
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 4.84
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 4.83
Transcriptome analysis of SKI knock-out in HL60 cells 4.76
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 4.76
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 4.73
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 4.72
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 4.67
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 4.66
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 4.66
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 4.66
The cohesin complex prevents Myc-induced replication stress 4.61
ETV7 and interferon response 4.53
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 4.53
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 4.52
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 4.43
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 4.39
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 4.39
Trans-differentiation of human adult peripheral blood T cells into neurons 4.37
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 4.35
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 4.35
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 4.29
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 4.29
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 4.28
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 4.19
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 4.14
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 4.12
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 4.09
Integrating single-cell transcriptomic data across different conditions, technologies, and species 4.06
Global analysis of enhancer targets: Mosaic-seq 4.03
HNF1A deficiency impairs β-cell fate, granule maturation and function 4.03
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 4.01
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 4.0
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 3.98
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 3.95
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 3.94
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.87
The Developmental Heterogeneity of Human Natural Killer Cells Defined by Single-cell Transcriptome 3.86
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 3.85
MYC dependent mRNA translation shapes gene expression and cell biology 3.84
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.83
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.83
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.82
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 3.82
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 3.8
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 3.77
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.74
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.74
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 3.72
Transcriptome-wide identification of CELF2 functional targets in T cells 3.72
Activation of neuronal genes via LINE-1 elements upon global DNA demethylation in human neural progenitors 3.71
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.7
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 3.66
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 3.65
A CLK3-HMGA2 alternative splicing axis impacts human hematopoietic stem cell molecular identity throughout development (HPC-5F RNAseq) 3.63
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 3.63
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 3.61
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 3.61
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.59
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 3.59
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 3.58
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 3.57
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 3.56
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 3.47
Identification of renal resident macrophages across species 3.45
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 3.45
scRNASeq analysis of cycling cardiomyocytes 3.44
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.43
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 3.41
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 3.41
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 3.4
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 3.38
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 3.38
Transcriptional profiling of LS1034 cells treated with tepoxalin 3.35
Spliceosomal disruption of the non-canonical BAF complex in cancer 3.35
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 3.35
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 3.34
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 3.34
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 3.33
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 3.32
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 3.31
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing [RNA-seq] 3.3
Multiplex Single Cell Profiling of Chromatin Accessibility by Combinatorial Cellular Indexing 3.3
Ribosomal footprinting of MDA-Parental and MDA-LM2 3.3
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 3.26
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 3.24
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 3.19
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.18
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.16
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 3.16
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.13
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.13
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 3.13
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 3.11
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 3.1
Definition of Natural Killer cell heterogeneity in humans and mice by high-throughput single-cell RNA sequencing 3.1
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.09
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 3.08
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 3.07
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.07
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 3.06
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 3.06
Helios enhances the preferential differentiation of human fetal CD4+ naïve T cells into regulatory T cells. [RNA-Seq - ex vivo] 3.06
Gene expression in GBM with Cav3.2 inhibition 3.04
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.03
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 3.01
Identification of transcription start sites for human A549 cell line using ReCappable-seq 3.01
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 3.01
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 3.01
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 3.0
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 2.99
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 2.98
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 2.97
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 2.97
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 2.95
Gene expression changes after LOC550643 silencing 2.95
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 2.94
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 2.93
PRDM1 inhibits proliferation of human colon cancer organoids 2.93
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.92
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 2.88
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 2.88
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 2.86
The Human Testis Cell Atlas via Single-cell RNA-seq 2.85
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.85
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.85
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 2.84
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 2.83
Single-cell RNA-seq reveals novel cell differentiation dynamics during human airway epithelium regeneration 2.82
Transcriptional change of THP-1 after HSV-1UL37WT or HSV-1UL37C819S 2.81
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 2.81
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 2.8
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.8
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 2.8
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 2.78
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 2.76
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 2.75
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 2.75
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 2.73
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 2.72
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 2.72
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 2.71
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 2.69
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.69
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.69
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 2.65
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.64
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 2.63
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 2.63
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 2.61
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 2.61
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 2.61
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 2.6
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 2.59
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 2.57
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 2.57
NHLRC1 re-expression in cancer cells 2.52
Hijacking of stress response machinery by oncogenes in acute leukaemia 2.52
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 2.52
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 2.5
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.5
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 2.46
Modulation of nonsense-mediated decay by rapamycin 2.43
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 2.42
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 2.41
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 2.37
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 2.34
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.33
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 2.32
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  2.31
GATA2 is Dispensable for Generation of Hemogenic Endothelium But Required for Endothelial-to-Hematopoietic Transition 2.31
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 2.23
RNA-seq of IL-4 stimulated human keratinocytes 2.22
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 2.2
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 2.18
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 2.18
Targeted enhancer activation by a subunit of the integrator complex 2.17
Transcriptome sequencing of K-562 cells 2.11
Gene expression analysis upon mtDNA depletion [RNA-seq] 2.1
Gene expression analysis upon mtDNA depletion 2.1
UV_24h_GRO-Seq 2.1
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 2.09
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 2.08
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.08
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 2.07
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 2.06
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 2.06
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 2.05
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 2.04
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 2.04
Transcription control by the ENL YEATS domain in acute leukemia 2.04
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 2.03
quanTIseq: quantifying immune contexture of human tumors 2.03
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 2.03
Differential expression analysis of RNA-seq data from melanocytes driven by tumor cell-derived exosomes 2.02
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 2.0
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.99
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 1.99
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.98
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.98
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.97
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.97
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.96
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 1.93
RNA-Seq from human ILC transitional populations 1.9
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.9
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 1.89
Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids 1.89
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 1.89
Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice 1.86
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 1.86
Human Treg NaCl stimulation 1.84
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.84
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 1.82
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 1.82
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 1.8
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 1.8
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.79
Overexpression and knockdown experiment for circCSNK1G3 1.76
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 1.75
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 1.75
Induction of extracellular adenosine salvage and metabolic quiescence regulate the transitional to follicular B cell checkpoint in humans. 1.74
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.74
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.74
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.72
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.68
MeRIP-seq for heat shock in B-cell lymphoma cells 1.67
Controlling for gene expression changes in transcription factor protein networks. 1.67
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 1.66
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.66
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 1.65
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.64
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.63
Regulation of poly(A) tail and translation during the somatic cell cycle 1.59
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (scRNA-Seq) 1.57
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 1.55
BACH2 in human plasma cell fate decision 1.55
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 1.54
Identification of Atrial Fibrillation associated genes and functional non-coding variants 1.52
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 1.5
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 1.49
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.46
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.45
Gene expression signatures of innate lymphoid cells from human blood 1.45
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 1.43
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.43
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.42
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.42
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.41
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 1.41
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.39
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 1.38
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 1.37
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 1.37
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 1.37
Functional significance of the HIV-1 Tat signature amino acid residues 1.37
RNAseq Analysis in glioblastoma cells treated with Mepazine 1.36
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 1.35
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 1.35
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 1.32
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.31
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.31
Gene expression profile in breast cancer cells 1.31
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 1.26
Ribosome profiling upon inhibition of eIF4A 1.24
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.19
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 1.19
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 1.18
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 1.18
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.18
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 1.15
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 1.14
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 1.14
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.14
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 1.14
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 1.14
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.13
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.13
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 1.13
Transcriptomic analysis of LSD1 1.12
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.12
Dissecting cell composition and cell-cell interaction network of human disease heart tissue by single-cell sequencing 1.12
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 1.11
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 1.1
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.09
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.09
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.05
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.05
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 1.04
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.02
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 1.02
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 1.0
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.99
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.99
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.99
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.98
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.98
Loss of CREBBP results in gene expression repression in lymphoma cells 0.97
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.97
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 0.96
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 0.95
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 0.94
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.94
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 0.93
IFN-γ Represses M2 Gene Expression in Human Macrophages by Suppressing and Disassembling MAF-binding Enhancers [RNA-seq] 0.92
Interferon-γ Represses M2 Gene Expression in Human Macrophages by Disassembling Enhancers Bound by the Transcription Factor MAF 0.92
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.91
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.88
U2AF1 mutations alter splice site recognition in hematological malignancies 0.88
H1609088 Human RNA-Sequencing 0.86
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 0.85
Total RNA-seq in ALL-SIL upon JQ1 inhibition 0.83
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 0.82
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.81
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.8
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 0.8
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.79
Expression analysis of the TAF1 syndrome 0.79
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.79
Gene expression analysis of human adenomas. 0.78
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 0.78
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 0.78
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.76
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.76
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.76
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 0.76
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 0.76
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.75
BASP1 modifies the Tamoxifen response 0.74
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.74
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.72
Transcriptome of human ILC2s; primary vs IL-1b-primed 0.72
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.71
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.71
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.68
Widespread intronic polyadenylation diversifies immune cell transcriptomes 0.68
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 0.64
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 0.63
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.62
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.62
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.6
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 0.6
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 0.6
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.6
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.59
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.57
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 0.55
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 0.54
Myc activation coordinates gene transcription and protein translation responses 0.54
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.53
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.53
Clinker: visualizing fusion genes detected in RNA-seq data 0.52
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 0.52
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.52
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 0.52
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 0.51
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.5
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.49
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 0.47
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.46
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.45
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.45
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.44
N6-methyladenine DNA Modification in Glioblastoma 0.44
A20 regulates canonical wnt-signaling through an interaction with RIPK4 0.43
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.43
RNA-seq of primary patient AML samples 0.43
p53 activity results in DNA replication fork processivity 0.41
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.41
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.41
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.39
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.39
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.39
Human cells contain natural double-stranded RNAs with potential regulatory capacity 0.38
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 0.37
Ribosomal protein RPL26 is the principal target of UFMylation 0.37
Comparative Analysis of Cas9 Activators Across Multiple Species 0.36
RNA-seq data 0.36
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 0.35
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.35
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 0.35
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 0.34
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.33
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.32
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.32
An evolutionary recent IFN-IL-6-CEBP axis is linked to monocyte expansion and tuberculosis severity in humans. 0.31
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.31
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.3
FOXO1 is an oncogenic mediator in AML1-ETO leukemia 0.3
Repurposing of promoters and enhancers during mammalian evolution 0.3
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 0.29
Effector and regulatory T cells roll at high shear stress by inducible tether and sling formation 0.29
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.28
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.27
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.27
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.27
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.25
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.25
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.24
Transcriptional profiling of microglia; current state of the art and future perspectives 0.24
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.24
High-resolution comparative analysis of great ape genomes 0.23
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.22
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 0.22
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 0.22
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.2
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 0.2
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 0.19
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 0.18
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 0.15
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.15
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 0.15
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 0.14
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 0.14
Transcriptome sequencing reveals aberrant alternative splicing in Huntington's disease 0.13
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.13
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.13
Oncogenic roles of ARID5B in T-ALL 0.13
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.09
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.09
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.09
Human MAIT cells exit peripheral tissues and re-circulate via lymph in steady state conditions 0.07
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.06
Transcriptional profile in human S. haematobium infection 0.05
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 0.04
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 0.04
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 0.04
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.03
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.02
Direct Isolation and Characterization of Human Nephron Progenitors. 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.02
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.02
Function and hormonal regulation of GATA3 in human first trimester placentation 0.02
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.02
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.02
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.01
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.01
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 0.01
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 0.01
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 0.01
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 0.01
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.0
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation